March 01, 2019
IN RE REVLIMID & THALOMID PURCHASER ANTITRUST LITIGATION
Case Number:
2:19-cv-07532
Court:
Nature of Suit:
Judge:
Firms
- Baldassare & Mara
- Boies Schiller
- Glancy Prongay
- Hangley Aronchick
- Hill Wallack
- Jones Day
- Kenny Nachwalter
- Lowey Dannenberg
- Miller Shah LLP
- Pashman Stein
- Spector Roseman
- Walsh Pizzi
Companies
- Blue Cross Blue Shield Association
- Bristol-Myers Squibb Co.
- Celgene Corp.
- CVS Health Corp.
- Dr. Reddy's Laboratories Ltd.
- Florida Blue
- Fraternal Order of Police
- Health Care Service Corp.
- Humana Inc.
- Intermountain Health
- Intermountain Healthcare Inc.
- Mayo Foundation for Medical Education and Research
- Teva Pharmaceutical Industries Ltd.
- The Cigna Group
Sectors & Industries:
View recent docket activity
Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.
Coverage
-
June 06, 2024
Drugmakers Escape Cancer Drug Antitrust Claims For Now
A New Jersey federal judge granted drugmakers Celgene and Bristol-Myers Squibb an out from consolidated antitrust litigation accusing them of delaying generic competition to their blockbuster cancer treatments, saying the conduct alleged by a group of insurer plaintiffs fails to amount to anti-competitive conduct.
Parties
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
- Direct access to case information and documents.
- All significant new filings across U.S. federal district courts, updated hourly on business days.
- Full-text searches on all patent complaints in federal courts.
- No-fee downloads of the complaints and so much more!
TRY LAW360 FREE FOR SEVEN DAYS
Already a subscriber? Click here to login